10-Q Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 Q1 2017

Filing Information

Form Type	10-Q
Accession Number	`0001564590-17-001023`
Period End Date	20161231
Filing Date	20170206
Fiscal Year	2017
Fiscal Period	Q1
XBRL Instance	arwr-20161231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 83 Income Statement 35 Cash Flow Statement 47 Stockholders Equity 10

Balance Sheet 83 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$81.21M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$62.17M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$102.11M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$85.37M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	15,652.00	shares	Point-in-time
Trade receivables	`AccountsReceivableNetCurrent`	$60.00K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	15,652.00	shares	Point-in-time
Trade receivables	`AccountsReceivableNetCurrent`	$75.00K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$569.41K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.29M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.50M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.77M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$90.50M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	74.41M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	69.75M	shares	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$106.23M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$16.17M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$15.39M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	69.75M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	74.41M	shares	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$21.74M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$22.16M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$122.33K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$122.33K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$144.26M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$128.18M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$12.23M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.70M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$4.59M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$4.76M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$2.15M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$3.97M	USD	Point-in-time
Deferred rent	`DeferredRentCreditCurrent`	$440.58K	USD	Point-in-time
Deferred rent	`DeferredRentCreditCurrent`	$440.58K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$2.57M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$25.58M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$118.80K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$1.60M	USD	Point-in-time
Note Payable	`NotesPayableCurrent`	$194.31K	USD	Point-in-time
Note Payable	`NotesPayableCurrent`	$197.71K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$46.41K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$46.41K	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$25.64M	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$37.00M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$2.27M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$2.19M	USD	Point-in-time
Deferred revenue, net of current portion	`DeferredRevenueNoncurrent`	$2.50M	USD	Point-in-time
Deferred revenue, net of current portion	`DeferredRevenueNoncurrent`	$5.18M	USD	Point-in-time
Note Payable, net of current portion	`LongTermNotesPayable`	$2.53M	USD	Point-in-time
Note Payable, net of current portion	`LongTermNotesPayable`	$2.48M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$200.00K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$200.00K	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$10.05M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$7.51M	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 0 and 15,652 shares issued and outstanding as of December 31, 2016 and September 30, 2016	`PreferredStockValue`	$16.00	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 74,413,040 and 69,746,685 shares issued and outstanding as of December 31, 2016 and September 30, 2016, respectively	`CommonStockValue`	$162.12K	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 74,413,040 and 69,746,685 shares issued and outstanding as of December 31, 2016 and September 30, 2016, respectively	`CommonStockValue`	$166.78K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$493.84M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$508.30M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$7.45K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-185.16K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-398.44M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-410.52M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$97.76M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$95.58M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$97.21M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.02M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$128.18M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$144.26M	USD	Point-in-time

Income Statement 35 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`Revenues`	$4.37M	USD	1 Quarter
REVENUE	`Revenues`	$43.75K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$10.34M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$9.53M	USD	1 Quarter
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$3.92M	USD	1 Quarter
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$4.28M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.95M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.85M	USD	1 Quarter
Stock-based compensation	`AllocatedShareBasedCompensationExpense`	$2.38M	USD	1 Quarter
Stock-based compensation	`AllocatedShareBasedCompensationExpense`	$2.42M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.19M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$794.35K	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$19.39M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$19.27M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-19.34M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-14.90M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$100.38K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$25.15K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-23.52K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$1.48M	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$1.31M	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$2.82M	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$76.86K	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-12.09M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-19.26M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-19.26M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-12.09M	USD	1 Quarter
NET LOSS PER SHARE - BASIC & DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.17	USD	1 Quarter
NET LOSS PER SHARE - BASIC & DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.32	USD	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	59.55M	shares	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	71.44M	shares	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$45.82K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-192.61K	USD	1 Quarter
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-19.22M	USD	1 Quarter
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-12.28M	USD	1 Quarter

Cash Flow Statement 47 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-19.26M	USD	1 Quarter
Net loss	`ProfitLoss`	$-12.09M	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-23.52K	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$1.48M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$2.38M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$2.42M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.19M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$794.35K	USD	1 Quarter
Amortization of note premiums	`InvestmentIncomeAmortizationOfPremium`	$108.40K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.05M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-15.00K	USD	1 Quarter
Prepaid expenses and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.03M	USD	1 Quarter
Prepaid expenses and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$490.06K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$25.65M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$257.22K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-4.65M	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-3.95M	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-1.85M	USD	1 Quarter
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$42.79K	USD	1 Quarter
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$-235.47K	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-21.15M	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$10.00M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$5.30M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$406.61K	USD	1 Quarter
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$3.00M	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-5.30M	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$2.59M	USD	1 Quarter
Principal payments on capital leases and notes payable	`RepaymentsOfLongTermCapitalLeaseObligations`	$54.05K	USD	1 Quarter
Principal payments on capital leases and notes payable	`RepaymentsOfLongTermCapitalLeaseObligations`	$47.28K	USD	1 Quarter
Payments of taxes for net share settled restricted stock unit issuances	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$417.14K	USD	1 Quarter
Payments of taxes for net share settled restricted stock unit issuances	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$440.53K	USD	1 Quarter
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$12.50M	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-494.58K	USD	1 Quarter
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$12.04M	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-19.05M	USD	1 Quarter
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$16.74M	USD	1 Quarter
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$81.21M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$62.17M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$102.11M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$85.37M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$81.21M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$62.17M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$102.11M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$85.37M	USD	Point-in-time
Interest paid	`InterestPaid`	$48.20K	USD	1 Quarter
Interest paid	`InterestPaid`	$3.05K	USD	1 Quarter
Property and Equipment expenditures included in accounts payable and accrued expenses	`PropertyAndEquipmentExpendituresIncludedInAccountsPayableAndAccruedExpenses`	$1.04M	USD	1 Quarter

Stockholders Equity 10 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$97.21M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.02M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.42M	USD	1 Quarter
Common stock- Restricted Stock Units vesting, Amount	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-381.56K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$45.82K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-192.61K	USD	1 Quarter
Net loss	`ProfitLoss`	$-19.26M	USD	1 Quarter
Net loss	`ProfitLoss`	$-12.09M	USD	1 Quarter
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$97.21M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.02M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.